SS Innovations International Inc. (NASDAQ: SSII), an American company headquartered in India, is advancing its SSi Mantra surgical robotic platform from a strong base in India into international markets, a move that could reshape global access to robotic surgery. The company reported second-quarter revenue of $13.9 million, up 39.4% year over year, and installed 30 systems during the quarter, bringing its total installed base to 224 systems across 12 countries. As of June 30, 2026, the platform has supported more than 12,000 cumulative procedures.
The SSi Mantra system is used across a range of surgical specialties, including cardiac, urology, gynecology, general and thoracic surgery. The company is also developing telesurgery capabilities, which could enable remote surgical procedures and extend specialized care to underserved regions. This diversification positions SS Innovations to compete in a rapidly growing market for robotic-assisted surgery, where demand is rising due to aging populations and the need for minimally invasive options.
SS Innovations is pursuing U.S. FDA 510(k) clearance and European CE marking, regulatory milestones that could substantially broaden its addressable market. If granted, these approvals would allow the company to enter two of the world’s largest healthcare markets, potentially accelerating revenue growth and adoption. The company’s focus on affordability and accessibility distinguishes it from established competitors, as it aims to make robotic surgery available to a larger segment of the global population.
For investors, the growth trajectory is notable. The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII. The full article detailing the company’s expansion can be viewed at https://nnw.fm/zbfTI. These resources provide ongoing insights into SS Innovations’ progress as it seeks to disrupt the surgical robotics landscape.
The announcement is significant for the healthcare industry because it signals intensifying competition in the surgical robotics market, which has long been dominated by a few players. Greater competition could lead to lower costs and increased innovation, benefiting hospitals and patients worldwide. SS Innovations’ cost-effective solutions may also make robotic surgery more accessible in emerging markets, where such technology has been largely unavailable.
NetworkNewsWire, a specialized communications platform focused on financial news and content distribution, published the original release. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries. The platform also offers article and editorial syndication to 5,000+ outlets and enhanced press release enhancement to ensure maximum impact. For more information, please visit NetworkNewsWire. Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer.
